Sionna Therapeutics, Inc.
SION · XNASCIK 2036042fmd_1HZ8TV2G980QQGDYHMYAQ1YAVKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2024 to Sep 30, 2026, 11 periods
| Line item | FY2024 | FY2025 |
|---|---|---|
| Research and development | 57 | 60 |
| Total operating expenses | 71 | 89 |
| Operating income | (71) | (89) |
| Interest and investment income | 8 | 13 |
| Other non-operating income (expense) | 9 | 14 |
| Income tax expense | 0 | 0 |
| Net income | (62) | (75) |